Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SBC - US73245B1070 - Common Stock

4.34 USD
-0.17 (-3.77%)
Last: 1/16/2026, 8:00:02 PM
4.34 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM

SBC Key Statistics, Chart & Performance

Key Statistics
Market Cap445.20M
Revenue(TTM)178.46M
Net Income(TTM)43.32M
Shares102.58M
Float9.87M
52 Week High7
52 Week Low2.62
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.54
PE8.04
Fwd PE8.68
Earnings (Next)03-26
IPO2022-09-26
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
SBC short term performance overview.The bars show the price performance of SBC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20

SBC long term performance overview.The bars show the price performance of SBC in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6 -8 -10

The current stock price of SBC is 4.34 USD. In the past month the price increased by 4.58%. In the past year, price decreased by -13.72%.

SBC MEDICAL GROUP HOLDINGS I / SBC Daily stock chart

SBC Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to SBC. When comparing the yearly performance of all stocks, SBC is a bad performer in the overall market: 74.9% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SBC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SBC. SBC has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SBC Financial Highlights

Over the last trailing twelve months SBC reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 48.69% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.28%
ROA 13.48%
ROE 17.47%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%300%
Sales Q2Q%-18.33%
EPS 1Y (TTM)48.69%
Revenue 1Y (TTM)10.85%

SBC Forecast & Estimates

6 analysts have analysed SBC and the average price target is 8.33 USD. This implies a price increase of 91.94% is expected in the next year compared to the current price of 4.34.

For the next year, analysts expect an EPS growth of -25.49% and a revenue growth -17.72% for SBC


Analysts
Analysts80
Price Target8.33 (91.94%)
EPS Next Y-25.49%
Revenue Next Year-17.72%

SBC Ownership

Ownership
Inst Owners0.84%
Ins Owners90.38%
Short Float %1.46%
Short Ratio2.38

SBC Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.47 99.78B
CI THE CIGNA GROUP 9.58 72.72B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 128.8 23.69B
LH LABCORP HOLDINGS INC 17.12 22.46B
DGX QUEST DIAGNOSTICS INC 19.41 21.08B
GH GUARDANT HEALTH INC N/A 14.45B
DVA DAVITA INC 11.35 7.39B
HIMS HIMS & HERS HEALTH INC 58.11 7.14B
BTSG BRIGHTSPRING HEALTH SERVICES 38.43 7.07B
CHE CHEMED CORP 20.54 6.40B
OPCH OPTION CARE HEALTH INC 24.18 5.72B
RDNT RADNET INC 186.82 5.48B

Related stock screener links

About SBC

Company Profile

SBC logo image SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

Company Info

SBC MEDICAL GROUP HOLDINGS I

200 Spectrum Center Dr., Suite 300

Irvine CALIFORNIA US

Employees: 863

SBC Company Website

SBC Investor Relations

Phone: 19495930250

SBC MEDICAL GROUP HOLDINGS I / SBC FAQ

What does SBC do?

SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.


Can you provide the latest stock price for SBC MEDICAL GROUP HOLDINGS I?

The current stock price of SBC is 4.34 USD. The price decreased by -3.77% in the last trading session.


Does SBC MEDICAL GROUP HOLDINGS I pay dividends?

SBC does not pay a dividend.


How is the ChartMill rating for SBC MEDICAL GROUP HOLDINGS I?

SBC has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the expected growth for SBC stock?

The Revenue of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -17.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the next earnings date for SBC stock?

SBC MEDICAL GROUP HOLDINGS I (SBC) will report earnings on 2026-03-26.